Back to search

Article

Thymidylate synthase disruption to limit cell proliferation in cell therapies

2023-06-26

Abstract excerpt

Engineered cells hold great promise for regenerative medicine and gene therapy. However, living cell products entail a fundamental biological risk of unwanted growth. Here, we describe a novel metabolic safety system to control cell proliferation without added genetic elements. We inactivated a key enzyme for nucleotide metabolism, TYMS , in several cell lines, thus obtaining cells that proliferate only when supp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
28f1b30d-4a61-5425-a162-25b53c8aea1a
DOI
10.1101/2023.06.26.546441
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Thymidylate synthase disruption to limit cell proliferation in cell therapiesDOI 10.1101/2023.06.26.546441
Select a neighboring publication to make it the new centre.